Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 121

    1.

    Computer-aided assessment of diagnostic images for epidemiological research.

    Abraham AG, Duncan DD, Gange SJ, West S.

    BMC Med Res Methodol. 2009 Nov 11;9:74.PMID: 19906311 [PubMed - in process]Related articlesFree article

    2.

    Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.

    Deeks SG, Gange SJ, Kitahata MM, Saag MS, Justice AC, Hogg RS, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Benson CA, Collier AC, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Kushel MB, Goedert JJ, McKaig RG, Moore RD.

    Clin Infect Dis. 2009 Nov 15;49(10):1582-90.PMID: 19845473 [PubMed - in process]Related articles

    3.

    Disclosure of complementary and alternative medicine use to health care providers among HIV-infected women.

    Liu C, Yang Y, Gange SJ, Weber K, Sharp GB, Wilson TE, Levine A, Robison E, Goparaju L, Ganhdi M, Merenstein D.

    AIDS Patient Care STDS. 2009 Nov;23(11):965-71.PMID: 19821723 [PubMed - in process]Related articles

    4.

    BMI <22.5 and >25 predicted higher overall mortality in adults.

    Cheskin LJ, Gange SJ.

    Evid Based Med. 2009 Oct;14(5):152. No abstract available. PMID: 19794027 [PubMed]Related articles

    5.

    Parametric models for studying time to antiretroviral resistance associated with illicit drug use.

    Sethi AK, Gange SJ.

    WMJ. 2009 Aug;108(5):266-8.PMID: 19743761 [PubMed - indexed for MEDLINE]Related articles

    6.

    Serum lipid profiles among patients initiating ritonavir-boosted atazanavir versus efavirenz-based regimens.

    Ganesan A, Benning L, Golub ET, Riddle M, Crum-Cianflone N, Tasker S, Jacobson L, Gange SJ.

    AIDS Res Ther. 2009 Jun 22;6:13.PMID: 19545433 [PubMed - in process]Related articlesFree article

    7.

    Competing risk regression models for epidemiologic data.

    Lau B, Cole SR, Gange SJ.

    Am J Epidemiol. 2009 Jul 15;170(2):244-56. Epub 2009 Jun 3.PMID: 19494242 [PubMed - indexed for MEDLINE]Related articles

    8.

    Evaluation of human immunodeficiency virus biomarkers: inferences from interval and clinical cohort studies.

    Lau B, Gange SJ, Kirk GD, Moore RD.

    Epidemiology. 2009 Sep;20(5):664-72.PMID: 19478669 [PubMed - in process]Related articles

    9.

    Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy.

    Dinoso JB, Kim SY, Wiegand AM, Palmer SE, Gange SJ, Cranmer L, O'Shea A, Callender M, Spivak A, Brennan T, Kearney MF, Proschan MA, Mican JM, Rehm CA, Coffin JM, Mellors JW, Siliciano RF, Maldarelli F.

    Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9403-8. Epub 2009 May 22.PMID: 19470482 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women.

    Gandhi M, Benet LZ, Bacchetti P, Kalinowski A, Anastos K, Wolfe AR, Young M, Cohen M, Minkoff H, Gange SJ, Greenblatt RM; Women's Interagency HIV Study.

    J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):482-91.PMID: 19408353 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of early versus deferred antiretroviral therapy for HIV on survival.

    Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Goedert JJ, Benson CA, Collier AC, Van Rompaey SE, Crane HM, McKaig RG, Lau B, Freeman AM, Moore RD; NA-ACCORD Investigators.

    N Engl J Med. 2009 Apr 30;360(18):1815-26. Epub 2009 Apr 1.PMID: 19339714 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy.

    Silverberg MJ, Jacobson LP, French AL, Witt MD, Gange SJ.

    J Pain Symptom Manage. 2009 Aug;38(2):197-207. Epub 2009 Mar 28.PMID: 19329274 [PubMed - indexed for MEDLINE]Related articles

    13.

    An instrumental variables evaluation of the effect of antidepressant use on employment among HIV-infected women using antiretroviral therapy in the United States: 1996-2004.

    Galárraga O, Salkever DS, Cook JA, Gange SJ.

    Health Econ. 2009 Feb 27. [Epub ahead of print]PMID: 19253267 [PubMed - as supplied by publisher]Related articles

    14.

    Relationship of injection drug use, antiretroviral therapy resistance, and genetic diversity in the HIV-1 pol gene.

    Kowalski J, Gange SJ, Schneider MF, Tsai HL, Templeton A, Shao Q, Zhang GW, Yeh MF, Young M, Markham RB.

    J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):381-9.PMID: 19214121 [PubMed - indexed for MEDLINE]Related articles

    15.

    Determinants of Newly Detected Human Papillomavirus Infection in HIV-Infected and HIV-Uninfected Injection Drug Using Women.

    Phelan DF, Gange SJ, Ahdieh-Grant L, Mehta SH, Kirk GD, Shah K, Gravitt P.

    Sex Transm Dis. 2009 Feb 9. [Epub ahead of print]PMID: 19174735 [PubMed - as supplied by publisher]Related articles

    16.

    Protease inhibitor levels in hair strongly predict virologic response to treatment.

    Gandhi M, Ameli N, Bacchetti P, Gange SJ, Anastos K, Levine A, Hyman CL, Cohen M, Young M, Huang Y, Greenblatt RM; Women's Interagency HIV Study (WIHS).

    AIDS. 2009 Feb 20;23(4):471-8.PMID: 19165084 [PubMed - indexed for MEDLINE]Related articles

    17.

    Quantification of sulforaphane mercapturic acid pathway conjugates in human urine by high-performance liquid chromatography and isotope-dilution tandem mass spectrometry.

    Egner PA, Kensler TW, Chen JG, Gange SJ, Groopman JD, Friesen MD.

    Chem Res Toxicol. 2008 Oct;21(10):1991-6. Epub 2008 Aug 26.PMID: 18729326 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men.

    Kaplan RC, Kingsley LA, Gange SJ, Benning L, Jacobson LP, Lazar J, Anastos K, Tien PC, Sharrett AR, Hodis HN.

    AIDS. 2008 Aug 20;22(13):1615-24.PMID: 18670221 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Determinants of incidence and clearance of high-risk human papillomavirus infections in rural Rakai, Uganda.

    Safaeian M, Kiddugavu M, Gravitt PE, Gange SJ, Ssekasanvu J, Murokora D, Sklar M, Serwadda D, Wawer MJ, Shah KV, Gray R.

    Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1300-7.PMID: 18559545 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Evaluating competing adverse and beneficial outcomes using a mixture model.

    Lau B, Cole SR, Moore RD, Gange SJ.

    Stat Med. 2008 Sep 20;27(21):4313-27.PMID: 18416435 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda.

    Safaeian M, Kiddugavu M, Gravitt PE, Gange SJ, Ssekasanvu J, Murokora D, Sklar M, Serwadda D, Wawer MJ, Shah KV, Gray R.

    Sex Transm Infect. 2008 Aug;84(4):306-11. Epub 2008 Apr 2.PMID: 18385223 [PubMed - indexed for MEDLINE]Related articles

    22.

    Teaching epidemiologic methods.

    Gange SJ.

    Epidemiology. 2008 Mar;19(2):353-6.PMID: 18277171 [PubMed - indexed for MEDLINE]Related articles

    23.

    Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV-infected women.

    Cocohoba J, Wang QJ, Cox C, Gange SJ, Cohen M, Glesby M, DeHovitz JA, Greenblatt RM.

    J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):377-83.PMID: 18176324 [PubMed - indexed for MEDLINE]Related articles

    24.

    Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.

    Golub ET, Benning L, Sharma A, Gandhi M, Cohen MH, Young M, Gange SJ.

    Clin Infect Dis. 2008 Jan 15;46(2):305-12.PMID: 18171267 [PubMed - indexed for MEDLINE]Related articles

    25.

    Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women.

    Lazo M, Gange SJ, Wilson TE, Anastos K, Ostrow DG, Witt MD, Jacobson LP.

    Clin Infect Dis. 2007 Nov 15;45(10):1377-85. Epub 2007 Oct 11.PMID: 17968839 [PubMed - indexed for MEDLINE]Related articles

    26.

    Ten-year predicted coronary heart disease risk in HIV-infected men and women.

    Kaplan RC, Kingsley LA, Sharrett AR, Li X, Lazar J, Tien PC, Mack WJ, Cohen MH, Jacobson L, Gange SJ.

    Clin Infect Dis. 2007 Oct 15;45(8):1074-81. Epub 2007 Sep 12.PMID: 17879928 [PubMed - indexed for MEDLINE]Related articles

    27.

    Association of cutaneous anergy with human papillomavirus and cervical neoplasia in HIV-seropositive and seronegative women.

    Harris TG, Burk RD, Xue X, Anastos K, Minkoff H, Massad LS, Young MA, Levine AM, Gange SJ, Watts DH, Palefsky JM, Strickler HD.

    AIDS. 2007 Sep 12;21(14):1933-41.PMID: 17721101 [PubMed - indexed for MEDLINE]Related articles

    28.

    Interval and clinical cohort studies: epidemiological issues.

    Lau B, Gange SJ, Moore RD.

    AIDS Res Hum Retroviruses. 2007 Jun;23(6):769-76.PMID: 17604539 [PubMed - indexed for MEDLINE]Related articles

    29.

    Injection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohorts.

    Morris JD, Golub ET, Mehta SH, Jacobson LP, Gange SJ.

    AIDS Res Ther. 2007 Jun 6;4:12.PMID: 17553140 [PubMed]Related articlesFree article

    30.

    Correlates of CD4+ and CD8+ lymphocyte counts in high-risk immunodeficiency virus (HIV)-seronegative women enrolled in the women's interagency HIV study (WIHS).

    Nowicki MJ, Karim R, Mack WJ, Minkoff H, Anastos K, Cohen M, Greenblatt RM, Young MA, Gange SJ, Levine AM.

    Hum Immunol. 2007 May;68(5):342-9. Epub 2007 Feb 15.PMID: 17462501 [PubMed - indexed for MEDLINE]Related articles

    31.

    Acquisition of new sexual partners among women with HIV infection: patterns of disclosure and sexual behavior within new partnerships.

    Wilson TE, Feldman J, Vega MY, Gandhi M, Richardson J, Cohen MH, McKaig R, Ostrow D, Robison E, Gange SJ.

    AIDS Educ Prev. 2007 Apr;19(2):151-9.PMID: 17411417 [PubMed - indexed for MEDLINE]Related articles

    32.

    Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy.

    Persaud D, Ray SC, Kajdas J, Ahonkhai A, Siberry GK, Ferguson K, Ziemniak C, Quinn TC, Casazza JP, Zeichner S, Gange SJ, Watson DC.

    AIDS Res Hum Retroviruses. 2007 Mar;23(3):381-90.PMID: 17411371 [PubMed - indexed for MEDLINE]Related articles

    33.

    Stability of the latent reservoir for HIV-1 in patients receiving valproic acid.

    Siliciano JD, Lai J, Callender M, Pitt E, Zhang H, Margolick JB, Gallant JE, Cofrancesco J Jr, Moore RD, Gange SJ, Siliciano RF.

    J Infect Dis. 2007 Mar 15;195(6):833-6. Epub 2007 Jan 30.PMID: 17299713 [PubMed - indexed for MEDLINE]Related articles

    34.

    Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).

    Gange SJ, Kitahata MM, Saag MS, Bangsberg DR, Bosch RJ, Brooks JT, Calzavara L, Deeks SG, Eron JJ, Gebo KA, Gill MJ, Haas DW, Hogg RS, Horberg MA, Jacobson LP, Justice AC, Kirk GD, Klein MB, Martin JN, McKaig RG, Rodriguez B, Rourke SB, Sterling TR, Freeman AM, Moore RD.

    Int J Epidemiol. 2007 Apr;36(2):294-301. Epub 2007 Jan 8. No abstract available. PMID: 17213214 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Reduced fertility among HIV-infected women associated with viral load in Rakai district, Uganda.

    Nguyen RH, Gange SJ, Wabwire-Mangen F, Sewankambo NK, Serwadda D, Wawer MJ, Quinn TC, Gray RH.

    Int J STD AIDS. 2006 Dec;17(12):842-6.PMID: 17212863 [PubMed - indexed for MEDLINE]Related articles

    36.

    Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3.

    Lau B, Gange SJ, Moore RD.

    J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):179-87.PMID: 17075385 [PubMed - indexed for MEDLINE]Related articles

    37.

    Combined analysis of retrospective and prospective occurrences in cohort studies: HIV-1 serostatus and incident pneumonia.

    Cole SR, Chu H, Allison PD, Gange SJ.

    Int J Epidemiol. 2006 Dec;35(6):1442-6. Epub 2006 Aug 26.PMID: 16936292 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Impact of inversion of the CD4/CD8 ratio on the natural history of HIV-1 infection.

    Margolick JB, Gange SJ, Detels R, O'Gorman MR, Rinaldo CR Jr, Lai S.

    J Acquir Immune Defic Syndr. 2006 Aug 15;42(5):620-6.PMID: 16868499 [PubMed - indexed for MEDLINE]Related articles

    39.

    Effectiveness of highly-active antiretroviral therapy by race/ethnicity.

    Silverberg MJ, Wegner SA, Milazzo MJ, McKaig RG, Williams CF, Agan BK, Armstrong AW, Gange SJ, Hawkes C, O'Connell RJ, Ahuja SK, Dolan MJ; Tri-Service AIDS Clinical Consortium Natural History Study Group.

    AIDS. 2006 Jul 13;20(11):1531-8.PMID: 16847408 [PubMed - indexed for MEDLINE]Related articles

    40.

    Longitudinal assessment of de novo T cell production in relation to HIV-associated T cell homeostasis failure.

    Chattopadhyay PK, Douek DC, Gange SJ, Chadwick KR, Hellerstein M, Margolick JB.

    AIDS Res Hum Retroviruses. 2006 Jun;22(6):501-7.PMID: 16796525 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Driving status and risk of entry into long-term care in older adults.

    Freeman EE, Gange SJ, Muñoz B, West SK.

    Am J Public Health. 2006 Jul;96(7):1254-9. Epub 2006 May 30.PMID: 16735633 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Longitudinal relationships between use of highly active antiretroviral therapy and satisfaction with care among women living with HIV/AIDS.

    Burke-Miller JK, Cook JA, Cohen MH, Hessol NA, Wilson TE, Richardson JL, Williams P, Gange SJ.

    Am J Public Health. 2006 Jun;96(6):1044-51. Epub 2006 May 2.PMID: 16670232 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study.

    Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts DH, Gandhi M, Mocharnuk RS, Anastos K.

    Am J Public Health. 2006 Jun;96(6):1060-5. Epub 2006 May 2.PMID: 16670229 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations.

    Ameli N, Bacchetti P, Morrow RA, Hessol NA, Wilkin T, Young M, Cohen M, Minkoff H, Gange SJ, Greenblatt RM.

    AIDS. 2006 Apr 24;20(7):1051-8.PMID: 16603858 [PubMed - indexed for MEDLINE]Related articles

    45.

    Assessing the effect of HAART on change in quality of life among HIV-infected women.

    Liu C, Weber K, Robison E, Hu Z, Jacobson LP, Gange SJ.

    AIDS Res Ther. 2006 Mar 20;3:6.PMID: 16549012 [PubMed]Related articlesFree article

    46.

    Screening HIV-positive pregnant women for antiretroviral therapy: utility of self-reported symptoms.

    Nguyen RH, Gange SJ, Serwadda D, Kigozi G, Kiwanuka N, Sewankambo NK, Wabwire-Mangen F, Quinn TC, Wawer M, Gray RH.

    Int J STD AIDS. 2006 Feb;17(2):112-5.PMID: 16464273 [PubMed - indexed for MEDLINE]Related articles

    47.

    C-reactive protein is a marker for human immunodeficiency virus disease progression.

    Lau B, Sharrett AR, Kingsley LA, Post W, Palella FJ, Visscher B, Gange SJ.

    Arch Intern Med. 2006 Jan 9;166(1):64-70.PMID: 16401812 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failure.

    Gange SJ, Schneider MF, Grant RM, Liegler T, French A, Young M, Anastos K, Wilson TE, Ponath C, Greenblatt R.

    J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):68-74.PMID: 16340476 [PubMed - indexed for MEDLINE]Related articles

    49.

    Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China.

    Kensler TW, Chen JG, Egner PA, Fahey JW, Jacobson LP, Stephenson KK, Ye L, Coady JL, Wang JB, Wu Y, Sun Y, Zhang QN, Zhang BC, Zhu YR, Qian GS, Carmella SG, Hecht SS, Benning L, Gange SJ, Groopman JD, Talalay P.

    Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2605-13.PMID: 16284385 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004.

    Schneider MF, Gange SJ, Williams CM, Anastos K, Greenblatt RM, Kingsley L, Detels R, Muñoz A.

    AIDS. 2005 Nov 18;19(17):2009-18.PMID: 16260908 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...